Pathogenic B-T Cell Axis Driven by BAFF Induces Endothelial Apoptosis in SLE-PAH
Circulation Research · 2026
DOI: 10.1161/circresaha.126.328338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, 2026. Verfasst von Xuehan Jiang und 22 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Med…. Hauptthemen laut MEDLINE: B-Cell Activating Factor, Lupus Erythematosus, Systemic, Apoptosis, B-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pulmonary arterial hypertension (PAH) is a fatal complication of systemic lupus erythematosus (SLE), yet the mechanisms linking autoimmune dysregulation to progressive pulmonary vascular remodeling are poorly defined, leading to inadequate therapies. This study investigated BAFF (B-cell activating factor), a key cytokine in SLE, as a potential driver of SLE-PAH pathogenesis. METHODS: BAFF expression was assessed in patients with SLE-PAH and animal models. Humanized BAFF-transgenic mice were generated to investigate the effects of BAFF elevation on serological, hemodynamic, and histological parameters of SLE and PAH. Single-cell RNA sequencing, flow cytometry, histological analyses, and cell-based experiments were performed to elucidate cellular and molecular mechanisms. The therapeutic efficacy of the BAFF-neutralizing antibody Belimumab was tested in 2 distinct SLE-PAH animal models. RESULTS: BAFF was significantly upregulated in both SLE-PAH patient cohorts and animal models. Humanized BAFF-transgenic mice exhibited systemic B-cell hyperactivation and pulmonary infiltration and spontaneously developed hallmark features of both SLE and PAH. Single-cell transcriptomic analysis of lung tissues revealed that BAFF overexpression drove the increase of a novel, disease-specific S 100a6 + mature B-cell subset, which orchestrated a pathogenic immune cascade by activating a cytotoxic Gzmk + CD8 + T-cell population via MHC-I (major histocompatibility complex class I)-mediated antigen presentation and CD80-CD28 costimulation. This B-T cell crosstalk triggered apoptosis of a susceptible endothelial cell subpopulation through Fas/Fas ligand signaling, ultimately culminating in pulmonary vascular remodeling. The BAFF-neutralizing antibody Belimumab effectively ameliorated both autoimmune and cardiopulmonary manifestations in 2 distinct SLE-PAH animal models, while improving survival. CONCLUSIONS: These findings establish BAFF as a key mediator in SLE-PAH, driving a previously unrecognized pathogenic immune axis connecting dysregulated B cells to T-cell-mediated endothelial injury. BAFF inhibition may represent a therapeutic strategy for SLE-PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China (X.J., H.…
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China (L.M., Y.L., X. Deng, Q.Y., X. Dong, Y.T., W.…
- National Clinical Research Center for Rheumatic and Autoimmune Diseases (NCRC-RAD), National Health Commission, Beijing, China (L.M., Y.L., X. Deng, Q.Y., X. Dong, Y.T., W.Z., J.Q., J. Zhao, Q.W., X.Z., M.L.).
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Ministry of Science & Technology, Beijing, China (L.M., Y.L., X. Deng, Q.Y., X. Dong, Y.T., W.Z., J.Q., J. Zhao, Q.W., X.Z…
- Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China (L.M., Y.L., X. Deng, Q.Y., X. Dong, Y.T., W.Z., J.Q., J. Zhao, Q.W., X.Z., M.L.).
- Beijing Key Laboratory of Intelligence and Precision in Rheumatic and Autoimmune Diseases, Beijing Municipal Commission of Science & Technology, China (L.M., Y.L., X. Deng, Q.Y., X. Dong, Y.T., W.Z., J.Q., J. Zhao, Q.W.…
ORCID-Profile: Xuehan Jiang, Leyao Ma, Xiaoyue Deng, Qizhi Yuan, Yidan Gao, Xingbei Dong, Junyan Qian, Yanjiang Xing, Yufei Hu, Jiuliang Zhao, Qian Wang, Yuanhua Yang, Wanlu Song, Mengtao Li, Peiran Yang
Zitieren
APA
Jiang, X., Ma, L., Li, Y., Deng, X., Yuan, Q., Zhang, J., Hu, H., Gao, Y., Dong, X., Tao, Y., Zhang, W., Qian, J., Xing, Y., Hu, Y., Zhang, H., Zhao, J., Wang, Q., Zeng, X., Yang, Y., …, & Wang, C. (2026). Pathogenic B-T Cell Axis Driven by BAFF Induces Endothelial Apoptosis in SLE-PAH. Circulation Research. https://doi.org/10.1161/circresaha.126.328338
Vancouver
Jiang X, Ma L, Li Y, Deng X, Yuan Q, Zhang J, et al. Pathogenic B-T Cell Axis Driven by BAFF Induces Endothelial Apoptosis in SLE-PAH. Circulation Research. 2026. doi:10.1161/circresaha.126.328338
BibTeX
@article{Jiang2026,
author = {Jiang, Xuehan and Ma, Leyao and Li, Yutong and Deng, Xiaoyue and Yuan, Qizhi and Zhang, Junwei and Hu, Huiyuan and Gao, Yidan and Dong, Xingbei and Tao, Yuhuan and Zhang, Wenjia and Qian, Junyan and Xing, Yanjiang and Hu, Yufei and Zhang, Hong and Zhao, Jiuliang and Wang, Qian and Zeng, Xiaofeng and Yang, Yuanhua and Song, Wanlu and Li, Mengtao and Yang, Peiran and Wang, Chen},
title = {Pathogenic B-T Cell Axis Driven by BAFF Induces Endothelial Apoptosis in SLE-PAH},
journal = {Circulation Research},
year = {2026},
doi = {10.1161/circresaha.126.328338}
}
EUVIMED